AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofeldt, F. D.
Right arrow Articles by Forsham, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofeldt, F. D.
Right arrow Articles by Forsham, P. H.
Agricola
Right arrow Articles by Hofeldt, F. D.
Right arrow Articles by Forsham, P. H.

American Journal of Clinical Nutrition, Vol 25, 1193-1201, Copyright © 1972 by The American Society for Clinical Nutrition, Inc.

Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administration

Fred D. Hofeldt M.D.1, Stephen Dippe M.D.1, and Peter H. Forsham M.D.1

1 From the Metabolic Research Unit, the General Clinical Research Center, and the Department of Medicine, University of California, San Francisco, California

Reactive hypoglycemia encompasses a spectrum of disorders which includes early alimentary reactive hypoglycemia, late diabetic reactive hypoglycemia, hormonal deficiency states with hypoglycemia, and idiopathic hypoglycemia. Transitional "hypoglycemia" should not be mistaken for one of the reactive-hypoglycemic states. Based on the approach we have proposed, the patient may be diagnosed after a 2-day evaluation that includes an OGTT and IVGTT. During the OGTT, particular attention is paid to the configuration of the glucose and insulin curves and posthypoglycemic cortisol and growth hormone responses.

The occurrence of typical symptoms at the nadir of blood glucose is an adequate indicator of an intact catecholamine system. An IVGTT separates the diabetic patients into insulinopenic and insulinoplethoric groups.

Based on the specific hypoglycemic disorder present, rational treatment may be instituted (22, 30, 56-58).




This article has been cited by other articles:


Home page
NEJMHome page
F.J. Service
Hypoglycemic Disorders
N. Engl. J. Med., April 27, 1995; 332(17): 1144 - 1152.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by The American Society for Nutrition